205 related articles for article (PubMed ID: 35269395)
21. Implications of Antimuscarinic Autoantibodies in Postural Tachycardia Syndrome.
Li H; Zhang G; Forsythe E; Okamoto LE; Yu X
J Cardiovasc Transl Res; 2022 Apr; 15(2):438-440. PubMed ID: 34409582
[TBL] [Abstract][Full Text] [Related]
22. Postural Orthostatic Tachycardia Syndrome (POTS)--A novel member of the autoimmune family.
Dahan S; Tomljenovic L; Shoenfeld Y
Lupus; 2016 Apr; 25(4):339-42. PubMed ID: 26846691
[TBL] [Abstract][Full Text] [Related]
23. Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome.
Garland EM; Gamboa A; Nwazue VC; Celedonio JE; Paranjape SY; Black BK; Okamoto LE; Shibao CA; Biaggioni I; Robertson D; Diedrich A; Dupont WD; Raj SR
J Am Coll Cardiol; 2021 May; 77(17):2174-2184. PubMed ID: 33926653
[TBL] [Abstract][Full Text] [Related]
24. Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance.
Garland EM; Celedonio JE; Raj SR
Curr Neurol Neurosci Rep; 2015 Sep; 15(9):60. PubMed ID: 26198889
[TBL] [Abstract][Full Text] [Related]
25. Proconvertase Furin Is Downregulated in Postural Orthostatic Tachycardia Syndrome.
Spahic JM; Ricci F; Aung N; Axelsson J; Melander O; Sutton R; Hamrefors V; Fedorowski A
Front Neurosci; 2019; 13():301. PubMed ID: 31001074
[No Abstract] [Full Text] [Related]
26. Postural Orthostatic Tachycardia Syndrome (POTS): An Update for Clinical Practice.
Sebastian SA; Co EL; Panthangi V; Jain E; Ishak A; Shah Y; Vasavada A; Padda I
Curr Probl Cardiol; 2022 Dec; 47(12):101384. PubMed ID: 36055438
[TBL] [Abstract][Full Text] [Related]
27. Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.
Olshansky B; Cannom D; Fedorowski A; Stewart J; Gibbons C; Sutton R; Shen WK; Muldowney J; Chung TH; Feigofsky S; Nayak H; Calkins H; Benditt DG
Prog Cardiovasc Dis; 2020; 63(3):263-270. PubMed ID: 32222376
[TBL] [Abstract][Full Text] [Related]
28. Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association.
Kohno R; Cannom DS; Olshansky B; Xi SC; Krishnappa D; Adkisson WO; Norby FL; Fedorowski A; Benditt DG
J Am Heart Assoc; 2021 Sep; 10(17):e021002. PubMed ID: 34398691
[TBL] [Abstract][Full Text] [Related]
29. [Postural orthostatic tachycardia syndrome (POTS): report of 15 cases].
Jiménez-Cohl P; Earle NM; González BR; Thieck EJ
Rev Med Chil; 2012 Feb; 140(2):145-52. PubMed ID: 22739942
[TBL] [Abstract][Full Text] [Related]
30. Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?
Blitshteyn S
J Neurol; 2022 Feb; 269(2):725-732. PubMed ID: 33677650
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
Reynolds GK; Lewis DP; Richardson AM; Lidbury BA
J Intern Med; 2014 Apr; 275(4):409-17. PubMed ID: 24206536
[TBL] [Abstract][Full Text] [Related]
32. The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability.
Moon J; Lee HS; Byun JI; Sunwoo JS; Shin JW; Lim JA; Kim TJ; Shin YW; Lee KJ; Jeon D; Jung KH; Lee ST; Jung KY; Chu K; Lee SK
J Am Soc Hypertens; 2016 Mar; 10(3):263-70. PubMed ID: 26857333
[TBL] [Abstract][Full Text] [Related]
33. Postural Orthostatic Tachycardia Syndrome (POTS) in Denmark: Increasingly recognized or new epidemic?
Brinth L; Pors K; Spahic JM; Sutton R; Fedorowski A; Mehlsen J
Auton Neurosci; 2018 Sep; 213():92-95. PubMed ID: 29530592
[TBL] [Abstract][Full Text] [Related]
34. Postural orthostatic tachycardia syndrome (POTS) and vitamin B12 deficiency in adolescents.
Öner T; Guven B; Tavli V; Mese T; Yilmazer MM; Demirpence S
Pediatrics; 2014 Jan; 133(1):e138-42. PubMed ID: 24366986
[TBL] [Abstract][Full Text] [Related]
35. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance.
Raj SR; Guzman JC; Harvey P; Richer L; Schondorf R; Seifer C; Thibodeau-Jarry N; Sheldon RS
Can J Cardiol; 2020 Mar; 36(3):357-372. PubMed ID: 32145864
[TBL] [Abstract][Full Text] [Related]
36. Pediatric-Onset Postural Orthostatic Tachycardia Syndrome in a Single Tertiary Care Center.
Staples A; Thompson NR; Moodley M
J Child Neurol; 2020 Jul; 35(8):526-535. PubMed ID: 32314650
[TBL] [Abstract][Full Text] [Related]
37. The preponderance of initial orthostatic hypotension in postural tachycardia syndrome.
Stewart JM; Kota A; O'Donnell-Smith MB; Visintainer P; Terilli C; Medow MS
J Appl Physiol (1985); 2020 Sep; 129(3):459-466. PubMed ID: 32702262
[TBL] [Abstract][Full Text] [Related]
38. Neurocardiogenic syncope coexisting with postural orthostatic tachycardia syndrome in patients suffering from orthostatic intolerance: a combined form of autonomic dysfunction.
Kanjwal K; Sheikh M; Karabin B; Kanjwal Y; Grubb BP
Pacing Clin Electrophysiol; 2011 May; 34(5):549-54. PubMed ID: 21208233
[TBL] [Abstract][Full Text] [Related]
39. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management.
Fedorowski A
J Intern Med; 2019 Apr; 285(4):352-366. PubMed ID: 30372565
[TBL] [Abstract][Full Text] [Related]
40. Use of an allostatic neurotechnology by adolescents with postural orthostatic tachycardia syndrome (POTS) is associated with improvements in heart rate variability and changes in temporal lobe electrical activity.
Fortunato JE; Tegeler CL; Gerdes L; Lee SW; Pajewski NM; Franco ME; Cook JF; Shaltout HA; Tegeler CH
Exp Brain Res; 2016 Mar; 234(3):791-8. PubMed ID: 26645307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
